Estimating the prevalence of problem drug use from drug‐related mortality data-Reference-Cited by-同舟云学术

Estimating the prevalence of problem drug use from drug‐related mortality data

Published:2020-06-09 Issue:12 Volume:115 Page:2393-2404
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Jones Hayley E.¹^ORCID,Harris Ross J.²,Downing Beatrice C.¹,Pierce Matthias³,Millar Tim³,Ades A. E.¹,Welton Nicky J.¹,Presanis Anne M.⁴,De Angelis Daniela²⁴,Hickman Matthew¹^ORCID

Affiliation:

1. Population Health Sciences, Bristol Medical School University of Bristol Bristol UK

2. Centre for Infectious Disease Surveillance and Control, Public Health England London UK

3. Division of Psychology and Mental Health, School of Health Sciences University of Manchester Manchester UK

4. MRC Biostatistics Unit University of Cambridge Cambridge UK

Funder

Medical Research Council

National Institute for Health Research

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.15111

Reference63 articles.

1. Monitoring the hepatitis C epidemic in England and evaluating intervention scale‐up using routinely collected data

2. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

3. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

4. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study

5. Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving Estimates of the Prevalence of Opioid Use Disorder in the United States: Revising Keyes et al;Journal of Addiction Medicine;2024-09-02

2. Providers’ knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study;Harm Reduction Journal;2024-08-16

3. National approaches to reduce mortality after prison release;The Lancet Public Health;2024-07

4. Prevalence of opioid dependence in Scotland 2015–2020: A multi‐parameter estimation of prevalence (MPEP) study;Addiction;2024-04-17

5. Estimation of the prevalence of opioid misuse in New York State counties, 2007-2018: a bayesian spatiotemporal abundance model approach;American Journal of Epidemiology;2024-03-06